Intuitive Surgical, Inc. $ISRG Stock Position Decreased by Flputnam Investment Management Co.

Flputnam Investment Management Co. trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 79.5% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 2,763 shares of the medical equipment provider’s stock after selling 10,740 shares during the period. Flputnam Investment Management Co.’s holdings in Intuitive Surgical were worth $1,236,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Norges Bank bought a new position in Intuitive Surgical during the second quarter valued at approximately $2,569,260,000. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after purchasing an additional 566,979 shares during the last quarter. Jennison Associates LLC boosted its holdings in Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after purchasing an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. increased its position in Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after buying an additional 371,806 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Royal Bank Of Canada raised their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Daiwa Capital Markets raised their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 15th. Wells Fargo & Company increased their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Finally, Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Stock Up 1.3%

Shares of NASDAQ ISRG opened at $579.83 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a market cap of $207.86 billion, a P/E ratio of 76.70, a P/E/G ratio of 5.26 and a beta of 1.68. The business’s 50 day moving average is $544.36 and its two-hundred day moving average is $505.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.84 earnings per share. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 7,562 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at $193,595.79. This trade represents a 95.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 114,007 shares of company stock worth $63,533,844. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.